Indicated for: Alzheimer's disease; dementia
Route of administration: oral
Substance: galantamine (cholinesterase inhibitor)
ATC: N06DA04 (Nervous system | Anti-dementia drugs | Anticholinesterases)
Galantaminum is a medication used for the symptomatic treatment of mild to moderate dementia associated with Alzheimer's disease. It works by inhibiting acetylcholinesterase, thereby increasing acetylcholine levels in the brain and improving cognitive function.
The medication is available in tablet form, extended-release capsules, or oral solution and should be taken as directed by a physician. Galantaminum can help slow the progression of Alzheimer's symptoms.
Common side effects include nausea, vomiting, diarrhea, and dizziness. It is important for patients to be monitored to prevent dehydration or other complications.
Galantaminum is an important therapeutic option for patients with Alzheimer's disease, helping to maintain independence and quality of life.